Mishima-gun, Japan

Rena Nishizawa

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • Mishima-gun, JP (2009 - 2012)
  • Osaka, JP (2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Rena Nishizawa: Innovator in Pharmaceutical Chemistry

Introduction

Rena Nishizawa is a prominent inventor based in Mishima-gun, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases. With a total of 5 patents to her name, her work has the potential to impact the treatment of numerous health conditions.

Latest Patents

One of Rena Nishizawa's latest patents involves a nitrogenous heterocyclic derivative and a medicine containing the same as an active ingredient. This compound, represented by a specific formula, exhibits antagonistic activity against CCR5. It is useful in preventing and treating CCR5-related diseases, including various inflammatory diseases such as asthma, nephritis, and arthritis. Additionally, it addresses immunological diseases, infectious diseases, allergic diseases, cardiovascular diseases, and even cancer metastasis.

Career Highlights

Throughout her career, Rena has worked with notable companies, including Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. Her expertise in pharmaceutical chemistry has allowed her to develop innovative solutions that address critical health issues.

Collaborations

Rena has collaborated with esteemed colleagues such as Yoshikazu Takaoka and Shiro Shibayama. These partnerships have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Rena Nishizawa's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…